CHMP recommends heart failure drug Entresto
The CHMP has adopted a positive opinion for Novartis’ Entresto…
25 September 2015 | By Victoria White
The CHMP has adopted a positive opinion for Novartis’ Entresto (sacubitril/valsartan), marking an important milestone towards the drug becoming available in the EU.